显著三尖瓣反流的进展及其预后意义:自然病史新见解
该回顾性注册研究纳入1000例既往无或轻度三尖瓣反流(TR)后进展为显著TR的患者,按两次超声间隔四分位分组。基线年龄、起搏器/除颤器导线、轻度TR、三尖瓣环收缩期位移降低及瓣环扩张与快速进展独立相关;快速进展者全因死亡风险更高。
要点
- 轻度TR、起搏/除颤导线及三尖瓣环扩张是显著TR快速进展的独立危险因素。
- 显著TR快速进展与全因死亡独立相关,风险比每提前一年为0.92。
- 对高风险患者加强超声随访,可能有助于早期干预改善生存。
核心结论
- 识别显著TR快速进展的高危患者后,密切超声随访可指示早期有效治疗以改善生存。
研究设计与样本
- 回顾性分析1000例(平均年龄68±13岁,50.9%男性)既往无/轻度TR后进展为显著TR的注册患者,排除先天性心脏病。
- 按两次超声间隔四分位分组:Group 1 ≤1.2年(n=251)、Group 2 1.3-4.7年(n=248)、Group 3 4.8-8.9年(n=251)、Group 4 ≥9.0年(n=250)。
主要发现
- 基线年龄(OR 1.02)、起搏器与除颤器导线(OR 1.59)、轻度(vs无)TR(OR 8.96)、三尖瓣环收缩期位移降低(OR 0.86)及三尖瓣环扩张(OR 1.06)与短期进展为显著TR独立相关。
- 两次超声间任何不伴三尖瓣手术的瓣膜手术与显著TR快速进展风险更高相关(OR 1.58)。
- 第二次超声(显著TR)后中位随访2.9年,42.1%患者死亡;快速进展者生存劣于缓慢进展者(log rank P=0.001)。
- 显著TR快速进展与全因死亡独立相关(风险比每提前一年:0.92,置信区间0.90-0.94;P<0.001)。
临床怎么用
- 对具有轻度TR、起搏/除颤导线、三尖瓣环扩张或收缩期位移降低等风险因素的患者,可考虑密切超声随访以早期发现显著TR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate the risk factors influencing the development of significant (moderate and severe) tricuspid regurgitation (TR), and its impact on all-cause mortality in large registry of referral centre. METHODS AND RESULTS: In 1000 patients (mean age 68 ± 13 years; 50.9% male) with documented significant TR, clinical, and echocardiographic data were retrospectively analysed when the echocardiogram showed none/mild TR. Patients with congenital heart disease were excluded. The study population was divided into quartiles according to the time interval between the two echocardiograms: Group 1: ≤1.2 years, n = 251; Group 2: 1.3-4.7 years, n = 248, Group 3: 4.8-8.9 years, n = 251; Group 4: ≥9.0 years, n = 250. Baseline age [odds ratio (OR) 1.02], presence of pacemaker and defibrillator lead (OR 1.59), presence of mild (vs. none) TR (OR 8.96), reduced tricuspid annulus plane systolic excursion (OR 0.86), and tricuspid annulus dilation (OR 1.06) were independently associated with development of significant TR in a short period of time. Any valvular surgery (without concomitant tricuspid surgery) occurring between both echocardiograms was also associated with a higher risk of fast development of significant TR (OR 1.58). During a median follow-up of 2.9 years after the second echocardiogram (with significant TR), 42.1% patients died. Patients with fast development of significant TR showed worse survival than patients with slower significant TR development (log rank P = 0.001). Fast development of significant TR was independently associated with all-cause mortality (hazard ratio per preceding year of development: 0.92, confidence interval 0.90-0.94; P < 0.001). CONCLUSION: By identifying patients at increased risk of developing significant TR, close echocardiographic surveillance can be indicated permitting effective therapy at an earlier stage to improve survival.
引用
- Prihadi EA, van der Bijl P, Gursoy E, et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur Heart J. 2018. PMID: 30010848. doi:10.1093/eurheartj/ehy352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。